81

Tianjin TEDA Biomedical Engineering Co LtdHKG 8189 Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Nov, 2024

Last price

Market cap $B

0.039

Micro

Exchange

XHKG - Hong Kong Exchange

8189.HK Stock Analysis

81

Uncovered

Tianjin TEDA Biomedical Engineering Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-32/100

Low score

Market cap $B

0.039

Dividend yield

Shares outstanding

1 894.5 B

Tianjin TEDA Biomedical Engineering Co. Ltd. provides research, development and commercialization of compound fertilizer and health care products. The company is headquartered in Tianjin, Tianjin and currently employs 344 full-time employees. The company went IPO on 2002-06-18. Its primary products include the series of biological compound fertilizer products for the promotion of balanced growth of grains, fruits and vegetables. These products are mainly sold under the brand of Fulilong. The Company’s businesses are mainly conducted in the People’s Republic of China (the PRC). The Company’s principal subsidiaries include Shandong Hidersun Fertiliser Industry Co., Ltd. and Guangdong Fulilong Compound Fertiliser Co., Ltd.

View Section: Eyestock Rating